Patient considerations and drug selection in the treatment of idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease of unknown cause. Approximately 5,000 people are diagnosed with IPF in the UK every year. People with IPF suffer significant morbidity and, without any curative treatment at present, survival rates remain poor with a medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Trawinska, Maria A, Rupesinghe, Ruwani D, Hart, Simon P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833375/
https://www.ncbi.nlm.nih.gov/pubmed/27114711
http://dx.doi.org/10.2147/TCRM.S81144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833375/
https://www.ncbi.nlm.nih.gov/pubmed/27114711
http://dx.doi.org/10.2147/TCRM.S81144

Ejemplares similares